日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

TCM soup can help cut COVID-19 death rate of patients in half, study shows

By WANG XIAOYU | CHINA DAILY | Updated: 2021-05-10 09:21
Share
Share - WeChat
Pharmacists dispense medicines according to Qingfei Paidu Soup prescriptions at Anhui University of Chinese Medicine on Feb 21, 2020. [Photo/Xinhua]

Qingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown.

The study examines more than 8,900 COVID-19 cases that received treatment at 15 hospitals in Hubei province-the hardest-hit region during the epidemic-from January to May last year, with nearly 30 percent of them having taken qingfei paidu as part of their therapies.

Results suggest that the mortality rate for those undergoing the TCM treatment stands at 1.2 percent, while the rate for other patients is 4.8 percent.

The study, led by researchers from Fuwai Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College, concluded that the use of qingfei paidu is associated with a 50 percent reduction of mortality in hospitalized COVID-19 patients, without amplifying the risk of developing acute liver or kidney injuries.

It was first published on preprint website MedRxiv.org in late December. On March 31, it was released on Phytomedicine, a peer-reviewed journal.

Li Jing, head of the research team, said based on the national diagnosis and treatment guideline for COVID-19 diseases, qingfei paidu is the only prescription that is recommended for treating all patients ranging from mild to critical cases.

"The extensive delivery of TCM medication in hospitalized patients during the outbreak had created a sound base for our research because when appraising clinical effectiveness of a certain drug, it is crucial to start by collecting and analyzing from a large enough number of cases," she said.

Qingfei paidu is a concoction that includes dozens of TCM herbs and roots, including ephedra, licorice root and bitter almond. The initial version of the prescription is believed to have originated during the Eastern Han Dynasty (25-220).

Zhang Boli, president of the Tianjin University of Traditional Chinese Medicine, said during an earlier interview that preliminary studies show the therapy mainly works on lungs while offering protection for some other organs against the virus. It can also stem the virus's replication, Zhang said.

According to the National Administration of Traditional Chinese Medicine, previous studies have already attested to the herbal prescription's efficacy in preventing mild and moderate cases from worsening into severe infections, but evidence of its role in lowering the death rate was lacking.

"The study is by far the largest clinical research on qingfei paidu and its findings have provided potent evidence for proving its marked efficacy in saving the lives of COVID-19 patients," the administration said.

As of now, there is no approved specific treatment for COVID-19 patients. During the fight against the epidemic, 92 percent of confirmed patients had undergone TCM therapies, with the efficacy rate in Hubei reaching 90 percent, according to a white paper released in June.

Li said the new study is retrospective and based on real-world cases.

"If a randomized, double-blind, placebo-controlled clinical study can be conducted in the future, the TCM drug's clinical efficacy can be further verified, and its global application is expected to expand," she added.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 黄色视频a级毛片 | 亚洲最大成人 | 精品黑人一区二区三区 | 亚洲电影免费观看高清完整版在线观 | 青青久久久国产线免观 | 欧美视频在线看 | 成年人在线播放视频 | 久久www免费人成看片色多多 | 欧美在线观看视频 | 亚洲午夜大片 | 国产精品久久久久久久久久免费 | 精品欧美一区二区三区精品久久 | 亚洲精品成人a | 国产亚洲欧美在线 | 一区二区三区欧美大片 | 成人破解版 | 国产午夜免费视频片夜色 | 色综合综合在线 | 91精品国产综合久久欧美 | 国产精品视频第一页 | 久久影城| 日韩欧美综合在线 | 欧美成人做性视频在线播放 | 午夜大片免费男女爽爽影院久久 | 女猛烈无遮挡性视频免费 | 成人黄色免费 | 日日碰狠狠躁久久躁婷婷 | 欧美精选在线 | 26uuu.mobi| 日韩欧美一区在线观看 | 国产亚洲精品久久久久久国 | 视频一区国产 | 春宵福利网站在线观看 | 日本久久久久久 | 日本黄色大片免费 | 日日夜夜天天人人 | 天干夜天天夜天干天 | 超级成人97碰碰碰免费 | 亚洲一区二区色 | 两性视频久久 | 亚洲欧美小视频 |